Today is a significant day in the fight against sexual harassment and discrimination. New laws come into effect from December 12, giving the Australian Human Rights Commission new powers to investigate sexual harassment and enforce outcomes.

Lawyer Prabha Nandagopal worked as senior legal advisor on the Human Rights Commission’s Respect @ Work inquiry. She is now the founder of Elevate Consulting Partners, advising businesses on this very topic, and talks to Sean Aylmer about what companies need to do to comply with the new rules.

Today is a significant day in the fight against sexual harassment and discrimination. New laws come into effect from December 12, giving the Australian Human Rights Commission new powers to investigate sexual harassment and enforce outcomes. Lawyer Prabha Nandagopal worked as senior legal advisor on the Human Rights Commission’s Respect @ Work inquiry. She is now the founder of <a href="https://www.google.com/url?q=https://www.elevateconsultingpartners.com.au/&amp;sa=D&amp;source=calendar&amp;ust=1702719879864063&amp;usg=AOvVaw1xg3cA6JSLu2qEMb4Jp4Gw">Elevate Consulting Partners</a>, advising businesses on this very topic, and talks to Sean Aylmer about what companies need to do to comply with the new rules.

Business news you can use. A daily business news podcast with journalists Sean Aylmer and Michael Thompson. Find out more at https://fearandgreed.com.au

Business news you can use. A daily business news podcast with journalists <a href="https://www.linkedin.com/in/sean-aylmer-9922068/" data-saferedirecturl="https://www.google.com/url?q=https://www.linkedin.com/in/sean-aylmer-9922068/&amp;source=gmail&amp;ust=1689199223540000&amp;usg=AOvVaw0wu3ezGEfBZFYspJbTTaYL">Sean Aylmer</a>&nbsp;and&nbsp;<a href="https://www.linkedin.com/in/mcwthompson/" data-saferedirecturl="https://www.google.com/url?q=https://www.linkedin.com/in/mcwthompson/&amp;source=gmail&amp;ust=1689199223540000&amp;usg=AOvVaw08pZ8jZ88rHJgCfbHkTr5k">Michael Thompson</a>.&nbsp;Find out more at&nbsp;<a href="https://protect-au.mimecast.com/s/7AmQCOMxmAtl5q0qiE-KY7?domain=fearandgreed.com.au/" data-saferedirecturl="https://www.google.com/url?q=https://protect-au.mimecast.com/s/7AmQCOMxmAtl5q0qiE-KY7?domain%3Dfearandgreed.com.au/&amp;source=gmail&amp;ust=1689199223540000&amp;usg=AOvVaw1DLq_FuqjEt3HC-ZK1704H">https://fearandgreed.com.au</a>

Fear and Greed is Australia's most popular business podcast.

FEAR & GREED | Business News

Business journalist Sean Aylmer talks to leaders about all things business in the Fear and Greed daily interview. 

Business journalist <a href="https://www.linkedin.com/in/sean-aylmer-9922068/">Sean Aylmer</a> talks to leaders about all things business in the <a href="https://fearandgreed.com.au/">Fear and Greed</a> daily interview.

Business journalist Sean Aylmer talks to leaders about all things business in Fear and Greed Interviews.

Fear and Greed Interviews

Daily business news for people who make their own decisions, with business journalist Sean Aylmer and Michael Thompson. Find out more at https://fearandgreed.com.au

Daily business news for people who make their own decisions, with business journalist <a href="https://www.linkedin.com/in/sean-aylmer-9922068/">Sean Aylmer</a> and <a href="https://www.linkedin.com/in/mcwthompson/">Michael Thompson</a>. Find out more at <a href="https://protect-au.mimecast.com/s/7AmQCOMxmAtl5q0qiE-KY7?domain=fearandgreed.com.au/">https://fearandgreed.com.au</a>

Interview: What all businesses need to know about today's law change

https://api.omny.fm/orgs/2fb3740d-3436-44af-8cc0-a91900716aa5/clips/8dce2db8-5b95-4687-9ff4-b0d500a08f46/transcript

Thursday 26 February 2026

Higher than expected inflation figures have upped the chance of an interest rate hike in coming months. 
The local sharemarket hits an all-time high
A bumper profit at Woolworths sends its share price up the most in 30 years 
AI bites, with WiseTech Global to cut 2,000 jobs
Donald Trump’s loud, abrasive State of the Union address

Join our free daily newsletter here.

And don’t miss the latest episode of How Do They Afford That? - this week, starting from scratch with money. Get the episode from APPLE, SPOTIFY, or anywhere you listen to podcasts.

Thursday 26 February 2026
Higher than expected inflation figures have upped the chance of an interest rate hike in coming months.&nbsp;
<ul>
<li aria-level="1">The local sharemarket hits an all-time high</li>
<li aria-level="1">A bumper profit at Woolworths sends its share price up the most in 30 years&nbsp;</li>
<li aria-level="1">AI bites, with WiseTech Global to cut 2,000 jobs</li>
<li aria-level="1">Donald Trump&rsquo;s loud, abrasive State of the Union address</li>
</ul>
Join our<a href="https://fearandgreed.com.au/newsletter-signup"> free daily newsletter here</a>.
And don&rsquo;t miss the latest episode of<a href="https://fearandgreed.com.au/how-do-they-afford-that-sugar-mamma-canna-campbell/"> How Do They Afford That?</a> - this week, starting from scratch with money. Get the episode from<a href="https://podcasts.apple.com/au/podcast/how-do-they-afford-that/id1644255235"> APPLE</a>,<a href="https://open.spotify.com/show/1EW5WRlRh7MovSBNkk6dG8?si=b2203ec2fa934a14"> SPOTIFY</a>, or anywhere you listen to podcasts.

Rate hike likely after CPI surprise; ASX record high; Trump’s rollicking State of the Union

Biotech company Imugene reported its half-year results yesterday. It’s still loss-making, but sharply cutting costs and seeing what appear to be genuinely encouraging clinical results.

Its lead cancer therapy, azer-cel, is showing strong response rates in difficult lymphoma cases, with some patients cancer-free for nearly two years - and the FDA has given positive feedback on the company’s strategy.

But at the same time, the company’s share price is down around 80pc over the last year.

Sean Aylmer speaks to Leslie Chong, CEO and Managing Director of Imugene, about what it takes to run a long-cycle biotech business, trying to develop life-changing treatments while keeping investors engaged.

Biotech company Imugene reported its half-year results yesterday. It&rsquo;s still loss-making, but sharply cutting costs and seeing what appear to be genuinely encouraging clinical results. Its lead cancer therapy, azer-cel, is showing strong response rates in difficult lymphoma cases, with some patients cancer-free for nearly two years - and the FDA has given positive feedback on the company&rsquo;s strategy. But at the same time, the company&rsquo;s share price is down around 80pc over the last year. Sean Aylmer speaks to Leslie Chong, CEO and Managing Director of Imugene, about what it takes to run a long-cycle biotech business, trying to develop life-changing treatments while keeping investors engaged.

Q+A: How this biotech CEO keeps the faith in a cancer cure

This is the Fear and Greed Afternoon Report - everything you need to know about what happened in the markets, economy and world of business today, in just a few minutes.


ASX hits record


Bumper crop of results


PM evacuated after bomb threat


Deloitte warns on ChatGPT


Louvre director resigns after robbery

Join our free daily newsletter here.

This is the&nbsp;<a href="https://fearandgreed.com.au/">Fear and Greed</a> Afternoon Report - everything you need to know about what happened in the markets, economy and world of business today, in just a few minutes.
<ol>
<li data-start="0" data-end="42">
ASX hits record
</li>
<li data-start="0" data-end="42">
Bumper crop of results
</li>
<li data-start="0" data-end="42">
PM evacuated after bomb threat
</li>
<li data-start="135" data-end="176">
Deloitte warns on ChatGPT
</li>
<li data-start="178" data-end="218" data-is-last-node="">
Louvre director resigns after robbery
</li>
</ol>
Join our <a href="https://fearandgreed.com.au/newsletter-signup">free daily newsletter here</a>.

Interview: What all businesses need to know about today's law change

In 1 playlist(s)

FEAR & GREED | Business News

Social links

Follow podcast

Recent clips